Tami L. Mark, PhD¹, Rita Vandivort-Warren, ACSW², Rosanna M. Coffey, PhD³, Henrick Harwood⁴, Joan D Dilonardo, PhD⁵, Ellen Bouchery⁴, Edward C King⁶, Jim Genuardi⁷, and David McKusick, PhD⁷. (1) Outcomes Research and Econometrics, Medstat, 4301 Connecticut Avenue, NW, Washington, DC 20008, 202-719-7832, Tami.Mark@Medstat.com, (2) Division of Policy Coordination, OPPB, OA, Substance Abuse & Mental Health Services Adm., HHS, 5600 Fishers Lane, Room 10-99, Parklawn Bldg, Rockville, MD 20857, (3) The Medstat Group, 4301 Connecticut Avenue, NW, Washington, DC 20008, (4) The Lewin Group, Inc, 3130 Fairview Park Drive, Suite 800, Falls Church, VA 22042, (5) Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, Rockwall II Building, Suite 740, 5515 Security Lane, Rockville, MD 20852, (6) Actuarial Research Corporation, 5513 Twin Knolls Road, Suite 213, Columbia, MD 21045, (7) The Actuarial Research Group, 5513 Twin Knolls Road, Suite 213, Columbia, MD 21045

OBJECTIVE: In this presentation the audience will learn how SUD treatment provider mix has changed over time. METHODS: The study employed numerous nationally representative databases and statistical and actuarial methods to develop estimates of expenditures by provider type. Trends are examined from 1991 to 2001. RESULTS: The providers that contributed the most to the growth in SA expenditures from 1991 to 2001 were specialty substance abuse centers (contributing 36% to the growth), multi-service mental health organizations (38%), and general hospitals (15%). Inpatient expenditures declined from representing 43% to only 22% of total SA spending over the 10 years. CONCLUSIONS: The mix of providers of SUD treatment has changed in important ways over the past decade.

Learning Objectives:

• In this presentation the audience will learn about how national expenditures on SUD treatment are distributed across different types of providers and how provider mix has changed over time

Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.